GIGALLOLINE Trademark

Trademark Overview


On Tuesday, November 7, 2023, a trademark application was filed for GIGALLOLINE with the United States Patent and Trademark Office. The USPTO has given the GIGALLOLINE trademark a serial number of 79390168. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 5, 2024. This trademark is owned by TREEFROG THERAPEUTICS. The GIGALLOLINE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseases, heart failure, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury and skin burns, spinal cord injuries, Huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases, functional microtissues that facilitate transplantation and graft integration; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseases, heart failure, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury and skin...

Stem cells for research; stem cells for scientific purposes; nutrition agents, namely, cell culture reagents for scientific and research use for processing living cells other than for medical purposes; cell culture media other than for medical and veterinary purposes

Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnology
gigalloline

General Information


Serial Number79390168
Word MarkGIGALLOLINE
Filing DateTuesday, November 7, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseases, heart failure, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury and skin burns, spinal cord injuries, Huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases, functional microtissues that facilitate transplantation and graft integration; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseases, heart failure, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury and skin burns, spinal cord injuries, Huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases, functional microtissues that facilitate transplantation and graft integration; stem cells for medical or veterinary use; pluripotent stem cells for medical use intended for cell and gene therapies; cultures of cell media for medical and veterinary use; surgical implants comprised of living tissues obtained from stem cells
Goods and ServicesStem cells for research; stem cells for scientific purposes; nutrition agents, namely, cell culture reagents for scientific and research use for processing living cells other than for medical purposes; cell culture media other than for medical and veterinary purposes
Goods and ServicesLaboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnology

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, February 23, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 23, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTREEFROG THERAPEUTICS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, February 22, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 27, 2024APPLICATION FILING RECEIPT MAILED
Saturday, June 15, 2024ASSIGNED TO EXAMINER
Saturday, June 15, 2024NON-FINAL ACTION WRITTEN
Sunday, June 16, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 28, 2024REFUSAL PROCESSED BY MPU
Friday, June 28, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, July 21, 2024REFUSAL PROCESSED BY IB
Monday, October 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER